| |
| Names | |
|---|---|
|
Preferred IUPAC name
2-(3,5-Dimethoxy-4-propoxyphenyl)ethan-1-amine | |
| Identifiers | |
|
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider | |
|
PubChem CID
|
|
| UNII | |
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C13H21NO3 | |
| Molar mass | 239.315 g·mol−1 |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Proscaline (4-propoxy-3,5-dimethoxyphenethylamine or 4-propoxy-3,5-DMPEA) is a psychedelic and hallucinogenic drug. It has structural properties similar to the drugs mescaline, isoproscaline, and escaline. In PiHKAL, Alexander Shulgin reports that a dose of 30–60 mg produces effects lasting 8–12 hours.
Chemistry
Proscaline is in a class of compounds commonly known as phenethylamines, and is the 4-propoxy homolog of mescaline. The full name of the chemical is 4-propoxy-3,5-dimethoxyphenethylamine.
Legality
Proscaline is a Class A controlled substance in the UK.
Proscaline is unscheduled and unregulated in the United States, but it could be considered an analog of a schedule I drug, mescaline, under the Federal Analog Act and thus be subject to the same control measures and penalties for possession and manufacture as a Schedule I drug.